Compare StocksNDAQ vs PFE

Nasdaq, Inc. (NDAQ) vs Pfizer Inc. (PFE): Which Is the Better Buy in 2026?

As of 2026-06-21, NDAQ is fairly valued at $82, with a DCF intrinsic value of $92 and a margin of safety of 11%. PFE is overvalued at $25, with an intrinsic value of $22 and a margin of safety of -12%. Of the two, NDAQ has the wider margin of safety.

NDAQ
Nasdaq, Inc.
$82.24
VS
PFE
Pfizer Inc.
$25.21

Rewards

NDAQ
  • Gross margin of 100.0% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Each dollar of retained earnings has created $4.31 of earning power — management is an exceptional capital allocator.
  • Trailing P/E of 24.8x is 21% below the historical average of 31.4x — potentially undervalued relative to its own history.
PFE
  • Gross margin of 74.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • FCF yield of 8.6% is historically attractive — the business generates significant cash relative to its price.
  • Trailing P/E of 19.2x is 37% below the historical average of 30.4x — potentially undervalued relative to its own history.

Risks

NDAQ
  • Share count has increased by 16% over the past 4 years, diluting existing shareholders.
  • 6 insider sales totaling $12.7M with no purchases in the past 3 months — insiders are reducing their exposure.
PFE
  • ROIC has declined by 15.9 percentage points over the past 4 years, which may signal competitive erosion.
  • PEG ratio of 13.77 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Free cash flow has declined at a 29.6% CAGR over the past 4 years — a concerning trend.

Key Valuation Metrics

Learn more →
NDAQ
PFE
Valuation
$1.56B
Free Cash Flow
$12.38B
3.35%
FCF Yield
8.61%
24.77
Trailing P/E
19.24
18.54
Forward P/E
8.91
Quality & Moat
9.61%
ROIC
10.19%
16.20%
ROE
8.31%
100.00%
Gross Margin
74.80%
2.00
PEG Ratio
13.77
Balance Sheet Safety
0.75
Net Debt / Equity
0.57
N/A
Interest Coverage
N/A
2.79
Net Debt / EBITDA
2.03
1.36%
Dividend Yield
6.82%
NDAQ: 3Ties: 1PFE: 8
NDAQPFE

Historical Fundamentals

Learn more →
NDAQ

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

PFE

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
NDAQ
$10.58
created per $1 retained over 3 years
Exceptional Value Creator
Σ Retained
$2.38B
Δ Market Cap
+$25.19B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
PFE
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-10.61B
Δ Market Cap
$-146.18B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
NDAQ
11.0% Margin of Safety
Price is 11.0% below estimated fair value
Current Price: $82.24
Fair Value: $92.35
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
PFE
12.3% Overvalued
Price is 12.3% above estimated fair value
Current Price: $25.21
Fair Value: $22.46
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
NDAQ

What growth rate is the market pricing in at $82?

+11.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +15.6%

The market implies +11.2% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding +15.6%, reflecting heavy growth investment expected to generate future returns.

PFE

What growth rate is the market pricing in at $25?

+5.2%
Market-Implied Owner Earnings Growth
Standard FCF implies +4.5%

The market implies +5.2% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +4.5%, reflecting heavy growth investment.

Economic Moat Score

Learn more →
NDAQ
60/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with reinvestment efficiency as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
PFE
35/100
No Moat
70+ Wide · 40-69 Narrow · <40 None

No durable moat detected, though reinvestment efficiency shows some competitive positioning. The business lacks consistent evidence of sustainable advantages.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 5 years of fundamental data.

Forensic Accounting

Learn more →
NDAQ
-2.58
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
PFE
-2.53
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
NDAQ
Insiders 10.9%Institutions 86.5%Retail & Other 2.6%
No. of Institutional Holders1,554
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
PFE
Insiders 0.1%Institutions 69.4%Retail & Other 30.5%
No. of Institutional Holders3,747
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
NDAQ
0
Buys (3M)
2
Buys (12M)
Total value (12M): $16.79M
TORGEBY JOHAN
Director
$958,320
@ $79.86 · 2026-02-17
INVESTOR AB
Beneficial Owner of more than 10% of a Class of Security
$15.84M
@ $79.18 · 2026-02-13
Open market purchases · includes direct & indirect ownership · excludes option exercises
PFE
0
Buys (3M)
0
Buys (12M)
BLAYLOCK RONALD E
Director
$499,072
@ $25.65 · 2025-02-13
GOTTLIEB SCOTT
Director
$28,240
@ $28.24 · 2024-10-30
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
NDAQ
6
Sells (3M)
22
Sells (12M)
Total value (12M): $84.03M
SMITH BRYAN EVERARD
Officer
$260,730
@ $86.91 · 2026-06-11
GRIGGS P C NELSON
Officer
$471,714
@ $92.62 · 2026-05-18
PETERSON BRADLEY J.
Chief Technology Officer
$700,222
@ $90.82 · 2026-04-28
TAL COHEN
Officer
$1.41M
@ $90.75 · 2026-04-27
DALY MICHELLE LYNN
Officer
$117,513
@ $88.82 · 2026-04-24
FRIEDMAN ADENA T
Chief Executive Officer
$9.71M
@ $85.44 · 2026-04-01
FRIEDMAN ADENA T
Chief Executive Officer
$8.36M
@ $90.08 · 2026-03-06
SMITH BRYAN EVERARD
Officer
$523,440
@ $87.24 · 2026-03-02
DALY MICHELLE LYNN
Officer
$352,934
@ $81.34 · 2026-02-19
FRIEDMAN ADENA T
Chief Executive Officer
$29.07M
@ $96.91 · 2026-02-02
ZECCA JOHN
Officer
$450,045
@ $100.01 · 2026-01-06
FRIEDMAN ADENA T
Chief Executive Officer
$28.92M
@ $96.39 · 2026-01-02
SKULE JEREMY
Officer
$190,650
@ $90.57 · 2025-12-01
SMITH BRYAN EVERARD
Officer
$419,611
@ $90.57 · 2025-12-01
SKULE JEREMY
Officer
$179,767
@ $85.40 · 2025-11-03
SKULE JEREMY
Officer
$185,703
@ $88.22 · 2025-10-01
SKULE JEREMY
Officer
$196,228
@ $93.22 · 2025-09-02
BEGLEY CHARLENE T
Director
$289,800
@ $96.60 · 2025-08-04
SKULE JEREMY
Officer
$201,006
@ $95.49 · 2025-08-01
DALY MICHELLE LYNN
Officer
$812,174
@ $93.45 · 2025-07-25
PETERSON BRADLEY J.
Chief Technology Officer
$1.02M
@ $88.87 · 2025-07-02
SKULE JEREMY
Officer
$187,703
@ $89.17 · 2025-07-01
SKULE JEREMY
Officer
$178,840
@ $85.00 · 2025-06-06
GRIGGS P C NELSON
Officer
$340,880
@ $85.22 · 2025-06-06
SKULE JEREMY
Officer
$87,694
@ $83.28 · 2025-06-02
GRIGGS P C NELSON
Officer
$664,240
@ $83.03 · 2025-05-27
SKULE JEREMY
Officer
$85,841
@ $81.52 · 2025-05-12
SMITH BRYAN EVERARD
Officer
$47,179
@ $71.81 · 2025-04-04
SMITH BRYAN EVERARD
Officer
$237,078
@ $75.70 · 2025-04-02
PETERSON BRADLEY J.
Chief Investment Officer
$174,646
@ $75.67 · 2025-04-02
YOUNGWOOD SARAH
Officer
$1.10M
@ $73.68 · 2025-03-17
SMITH BRYAN EVERARD
Officer
$289,730
@ $82.78 · 2025-03-03
PETERSON BRADLEY J.
Officer
$1.36M
@ $79.79 · 2025-02-26
TAL COHEN
Officer
$749,981
@ $83.75 · 2025-02-06
SMITH BRYAN EVERARD
Officer
$285,460
@ $81.56 · 2025-02-03
SKULE JEREMY
Officer
$976,485
@ $80.88 · 2024-12-09
SKULE JEREMY
Officer
$950,906
@ $78.75 · 2024-11-18
PETERSON BRADLEY J.
Officer
$940,636
@ $79.58 · 2024-11-13
GRIGGS P C NELSON
Officer
$798,600
@ $79.86 · 2024-11-11
SKULE JEREMY
Officer
$935,040
@ $77.92 · 2024-11-06
GRIGGS P C NELSON
President
$444,086
@ $77.34 · 2024-11-06
TAL COHEN
Officer
$806,651
@ $74.11 · 2024-11-01
GRIGGS P C NELSON
Officer
$758,460
@ $75.85 · 2024-10-29
PETERSON BRADLEY J.
Officer
$1.03M
@ $75.32 · 2024-10-28
ZECCA JOHN
Officer
$791,670
@ $71.97 · 2024-09-12
PETERSON BRADLEY J.
Officer
$2.71M
@ $67.79 · 2024-08-09
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
PFE
1
Sells (3M)
1
Sells (12M)
Total value (12M): $51,400
DAMICO JENNIFER B.
Officer
$51,400
@ $25.70 · 2026-06-09
DAMICO JENNIFER B.
Officer
$64,825
@ $25.93 · 2025-03-04
DAMICO JENNIFER B.
Officer
$147,714
@ $28.66 · 2024-08-13
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
NDAQ
FearGreed
😨Fear(37/100)

"Market is pessimistic — investigate whether fears are temporary or structural"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
PFE
FearGreed
😐Neutral(49/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
NDAQ
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Fear (37)
PFE
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (49)
View NDAQ Full AnalysisView PFE Full Analysis

Frequently Asked Questions: NDAQ vs PFE

Is Nasdaq, Inc. or Pfizer Inc. more undervalued in 2026?

Based on our discounted cash flow model, NDAQ trades at a 11.0% margin of safety (intrinsic value $92 vs. price $82), compared to PFE's -12.3% margin of safety (intrinsic $22 vs. $25).

Which stock has a wider economic moat, Nasdaq, Inc. or Pfizer Inc.?

NDAQ scores 60/100 (Narrow moat), while PFE scores 35/100 (None moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Pfizer Inc. in financial distress?

PFE's Altman Z-Score of 2.1 places it in the Grey zone, signaling elevated bankruptcy risk. NDAQ scores 2.7 (Grey zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Nasdaq, Inc. or Pfizer Inc.?

Pfizer Inc. (PFE) generates a 8.6% free cash flow yield, compared to Nasdaq, Inc.'s 3.4%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Nasdaq, Inc. or Pfizer Inc.?

PFE earns 10.2% ROIC versus NDAQ's 9.6%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Nasdaq, Inc.'s or Pfizer Inc.'s?

NDAQ's dividend earns a safety score of 91/100 (Very Safe), compared to PFE's 24/100 (Unsafe). NDAQ has raised its dividend for 2 consecutive years.